JHU ISCRO Approved hESC Lines

Provider

Name of Line

Provider Code

JHU ISCRO Approval

Columbia University1018NT1018NT2/2/2018

ES Cell International

ES01

HES-1

11/10/2008

ES Cell International

ES02

HES-2

11/10/2008

ES Cell International

ES03

HES-3

11/10/2008

Harvard University

HUES PGD 11

HUES PGD 11

12/09/2013

Harvard University

HUES PGD 12

HUES PGD 12

12/09/2013

Harvard University HUES 63HUES 63

1/14/2016

Harvard University HUES6HUES67/14/2022
Harvard University HUES8HUES8

3/23/2022

Harvard University HUES9HUES9

7/18/2022

Harvard University HUES13HUES13

7/18/2022

The Rockefeller UniversityRUES1RUES1

7/13/2015

The Rockefeller UniversityRUES2RUES2

7/13/2015

The Rockefeller UniversityRUES3RUES32/19/2018
Stem Cell Ltd.
 
MEL-1MEL-11/26/2017 

Stemride International

SC-233

SC-233

04/14/2008

Stemride International

SC-164

SC-164

04/14/2008

UK Stem Cell Bank

SHEF-3

SHEF-3

11/14/2011

University of California, San Francisco

UC06

HSF-6

11/10/2008

WiCell

WA01

H1

02/12/2007

WiCell

WA07

H7

05/09/2011

WiCell

WA09

H9

02/12/2007

WiCell

WA13

H13

01/14/2008

It is important to note that hESC lines listed on the JHU ISCRO Registry might not be listed on the NIH Registry and eligible for research using federal funds.

If you have questions about this, or are considering use of a hESC line not listed on this registry, please contact Andrew Tomar, JHU ISCRO Administrator, via [email protected].